This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Duquesne University. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Moji Christianah Adeyeye: Innovator in Ophthalmic Drug Delivery Systems
Introduction: Moji Christianah Adeyeye is a prominent inventor based in Schaumburg, Illinois, with expertise in developing innovative solutions for ophthalmic drug delivery. Her work focuses on advancing medical technology to enhance patient care, particularly in the prevention of cataracts.
Latest Patents: Adeyeye holds a notable patent for an "in-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts." This innovative system incorporates an estrogen, a solubilizing and complexing agent, a humectant, sorbic acid or a sorbic acid-based stabilizer, an optional chelating agent, and gellan gum. The formulation is designed to improve the delivery and effectiveness of ocular treatments, with a concentration range of about 0.1-0.5% w/v.
Career Highlights: Moji Christianah Adeyeye is affiliated with Duquesne University of the Holy Spirit, where she contributes her expertise in pharmaceutical sciences and drug development. Her background and ongoing research are pivotal in the realm of ophthalmology, with a focus on creating effective therapeutic modalities for eye care.
Collaborations: Throughout her career, Adeyeye has collaborated with other talented professionals, including Vicki L. Davis and Uday K. Kotreka. These partnerships signify her commitment to teamwork and knowledge-sharing within the scientific community, fostering advancements in her field.
Conclusion: Moji Christianah Adeyeye exemplifies innovation in the healthcare sector through her groundbreaking work in ophthalmic drug delivery systems. Her patent highlights her dedication to improving medical treatments, securing her position as a key inventor in the field. As she continues her research, her contributions are set to pave the way for future advancements in ophthalmology and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
